Thursday, December 18, 2025
Thursday, December 18, 2025

The first study of the use of microarray patches to vaccinate children has shown that the method is safe and induces strong immune responses. The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that painlessly penetrate the skin and deliver the vaccine, or by conventional injection with a needle and syringe.

More Articles …

  1. Study finds school entry requirements linked to increased HPV vaccination rates
  2. One in eight grown-ups love extreme tartness
  3. Enzymes open new path to universal donor blood
  4. Possible alternative to antibiotics produced by bacteria
  5. AI algorithms can determine how well newborns nurse, study shows
  6. After 25 years, researchers uncover genetic cause of rare neurological disease
Page 1366 of 1936